Literature DB >> 29107793

Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation.

Narawat Nuamnaichati1, Vilasinee Hirunpanich Sato1, Primchanien Moongkarndi2, Warisara Parichatikanond1, Supachoke Mangmool3.   

Abstract

Paracrine factors, including growth factors and cytokines, released from cardiac myocytes following β-adrenergic receptor (β-AR) stimulation regulate cardiac fibroblasts. Activated cardiac fibroblasts have the ability to increase collagen synthesis, cell proliferation and myofibroblast differentiation, leading to cardiac fibrosis. However, it is unknown which β-AR subtypes and signaling pathways mediate the upregulation of paracrine factors in cardiac myocytes. In this study, we demonstrated that sustained stimulation of β-ARs significantly induced synthesis and secretion of growth factors, including connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF), via the cAMP-dependent and protein kinase A (PKA)-dependent pathways. In addition, isoproterenol (ISO)-mediated synthesis and secretion of CTGF and VEGF through the β1-AR and β2-AR subtypes. Paracrine factors released by cardiac myocytes following sustained β-AR stimulation are necessary for the induction of cell proliferation and synthesis of collagen I, collagen III and α-smooth muscle actin (α-SMA) in cardiac fibroblasts, confirming that β-AR overstimulation of cardiac myocytes induces cardiac fibrosis by releasing several paracrine factors. These effects can be antagonized by β-blockers, including atenolol, metoprolol, and propranolol. Thus, the use of β-blockers may have beneficial effects on the treatment of myocardial fibrosis in patients with heart failure.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac fibroblast; Cardiac myocyte; PKA; Paracrine factor; cAMP; β-Adrenergic receptor

Mesh:

Substances:

Year:  2017        PMID: 29107793     DOI: 10.1016/j.lfs.2017.10.034

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  Epac is required for exogenous and endogenous stimulation of adenosine A2B receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation.

Authors:  Sarawuth Phosri; Kwanchai Bunrukchai; Warisara Parichatikanond; Vilasinee H Sato; Supachoke Mangmool
Journal:  Purinergic Signal       Date:  2018-01-10       Impact factor: 3.765

Review 2.  The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.

Authors:  Yukang Mao; Kun Zhao; Peng Li; Yanhui Sheng
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

3.  Chronic peripheral ghrelin injection exerts antifibrotic effects by increasing growth differentiation factor 15 in rat hearts with myocardial fibrosis induced by isoproterenol.

Authors:  Q Ren; P Lin; Q Wang; B Zhang; L Feng
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

Review 4.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

Review 5.  Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.

Authors:  Supachoke Mangmool; Warisara Parichatikanond; Hitoshi Kurose
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

6.  Cardiac Progenitor Cells: The Matrix Has You.

Authors:  Clotilde Castaldo; Isotta Chimenti
Journal:  Stem Cells Transl Med       Date:  2018-04-24       Impact factor: 6.940

7.  Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats.

Authors:  Yan Che; Di-Fei Shen; Zhao-Peng Wang; Ya-Ge Jin; Qing-Qing Wu; Sha-Sha Wang; Yuan Yuan
Journal:  BMC Cardiovasc Disord       Date:  2019-10-15       Impact factor: 2.298

8.  Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.

Authors:  Lejla Medzikovic; Hylja Heese; Pieter B van Loenen; Cindy P A A van Roomen; Ingeborg B Hooijkaas; Vincent M Christoffels; Esther E Creemers; Carlie J M de Vries; Vivian de Waard
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

9.  Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track.

Authors:  Sara A El-Wakeel; Rania M Rahmo; Hanan S El-Abhar
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

Review 10.  Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling.

Authors:  Warisara Parichatikanond; Theerut Luangmonkong; Supachoke Mangmool; Hitoshi Kurose
Journal:  Front Cardiovasc Med       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.